Standard Contracts
RESEARCH FUNDING AGREEMENT by and between THE SCRIPPS RESEARCH INSTITUTE a California nonprofit public benefit corporation and ChromaPharma, Inc. A Nevada corporation RESEARCH FUNDING AGREEMENTResearch Funding Agreement • August 10th, 2017 • ChromaDex Corp. • Medicinal chemicals & botanical products • California
This Agreement is entered into this 5th day of June, 2017 (the “Effective Date”), by and between The Scripps Research Institute, a California nonprofit public benefit corporation located at 10550 North Torrey Pines Road, La Jolla, California 92037 ("TSRI"), and ChromaPharma, Inc., a Nevada for-profit corporation located at 10005 Muirlands Blvd., Suite G, Irvine, CA 92618 USA ("Sponsor"), with respect to the facts set forth below.
THIRD BUSINESS FINANCING MODIFICATION AGREEMENTBusiness Financing Modification Agreement • August 10th, 2017 • ChromaDex Corp. • Medicinal chemicals & botanical products
This Third Business Financing Modification Agreement (this “Agreement”) is entered into as of April 19, 2017, by and among CHROMADEX CORPORATION, a Delaware corporation, CHROMADEX, INC., a California corporation, CHROMADEX ANALYTICS, INC., a Nevada corporation (“Existing Borrowers”) and HEALTHSPAN RESEARCH LLC, a Delaware limited liability company (“New Borrower”, and together with Existing Borrowers, each, a “Borrower” and collectively, “Borrowers”), and WESTERN ALLIANCE BANK, an Arizona corporation (“Lender”).
LICENSE AGREEMENTLicense Agreement • August 10th, 2017 • ChromaDex Corp. • Medicinal chemicals & botanical products • California
This License Agreement is effective as of June 5, 2017 (the “Effective Date”), by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation ("TSRI"), and ChromaPharma, Inc. a Nevada corporation ("Licensee"), each located at the respective address set forth in Section 13.17 below, with respect to the facts set forth below.
FOURTH BUSINESS FINANCING MODIFICATION AGREEMENTBusiness Financing Modification Agreement • August 10th, 2017 • ChromaDex Corp. • Medicinal chemicals & botanical products
This Fourth Business Financing Modification Agreement (this “Agreement”) is entered into as of July 13, 2017, by and among CHROMADEX CORPORATION, a Delaware corporation, CHROMADEX, INC., a California corporation, CHROMADEX ANALYTICS, INC., a Nevada corporation and HEALTHSPAN RESEARCH LLC, a Delaware limited liability company (each, a “Borrower” and collectively, “Borrowers”), and WESTERN ALLIANCE BANK, an Arizona corporation (“Lender”).
